Delayed Developmental Effects Following Prenatal Exposure to Drugs
Authors: Mantovani, A.; Calamandrei, G.
Source: Current Pharmaceutical Design, Volume 7, Number 9, 1 June 2001 , pp. 859-880(22)
Publisher: Bentham Science Publishers
Abstract:
Increasing evidence points to the possible risks of delayed effects upon prenatal exposure to chemicals; the evaluation of such effects may pose serious problems to clinicians, epidemiologists and toxicologists. In fact, several systems (e.g., nervous, excretory) show important developmental processes well after the organogenetic period, up to the postnatal phase; accordingly, these are also expected to be sensitive targets of developmental toxicants, resulting in impairment of the function and/or functional reserve. This review describes the effects of several groups of drugs on the functional maturation and histogenesis of the kidney (e.g., aminoglycosides, angiotensin-converting enzyme inhibitors, indomethacin) and brain (e.g., anticonvulsivants, antiretroviral compounds, benzodiazepines) upon exposure in utero of humans and laboratory animals. The available data stress the importance for risk assessment of an adequate knowledge of both developmental biology and mechanisms of toxicity. The design of developmental toxicity studies should allow an evaluation of targets most relevant for a given drug (or group of drugs); moreover, the analysis of functional development should receive the due attention within the safety assessment of chemicals.Keywords: aminoglycosides angiotensin-converting enzyme inhi; Aminoglycosides; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); dexamethasone; Glucocorticoids; Diuretic Agents; acetazolamide; amiloride; chlorothiazide
Document Type: Review article
DOI: http://dx.doi.org/10.2174/1381612013397717
Publication date: 2001-06-01
- Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.
- In this: publication
- By this: publisher
- In this Subject: Pharmacology
- By this author: Mantovani, A. ; Calamandrei, G.

Shopping cart
Receive new issue alert
Get Permissions